I

Inovio Pharmaceuticals
D

INO

4.06000
USD
0.07
(1.75%)
Market Closed
Volume
0
EPS
-4
Div Yield
-
P/E
-1
Market Cap
105,414,928
OverviewSignalsIdeasNews
Related Instruments
    A
    AMRN
    -0.01500
    (-2.88%)
    0.50510 USD
    A
    APTX
    0
    (0%)
    0.000000 USD
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    A
    AXSM
    -4.300
    (-4.41%)
    93.150 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    I
    INO
    -0.54000
    (-11.25%)
    4.26000 USD
    S
    SRPT
    -4.470
    (-4.10%)
    104.600 USD
    V
    VCEL
    -0.240
    (-0.46%)
    52.510 USD
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    More
News

Title: Inovio Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.